In contrast, KMT2A rearrangements were associated with the loss of markers, including CD10 (Pro-B ALL phenotype), and were negatively associated with CD66c, CD73, and CD304 positivity. The gene discussed is NT5E; the disease is acute lymphoblastic leukemia.